Stryker PE Ratio 2010-2025 | SYK

Current and historical p/e ratio for Stryker (SYK) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Stryker PE ratio as of July 25, 2025 is 32.21.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Stryker PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-25 403.53 54.53
2025-03-31 371.46 $7.40 50.20
2024-12-31 358.45 $7.76 46.19
2024-09-30 358.82 $9.33 38.46
2024-06-30 337.21 $8.97 37.59
2024-03-31 353.84 $8.76 40.39
2023-12-31 295.41 $8.25 35.81
2023-09-30 268.85 $6.74 39.89
2023-06-30 299.31 $7.08 42.28
2023-03-31 279.36 $6.87 40.66
2022-12-31 238.62 $6.17 38.67
2022-09-30 197.06 $6.43 30.65
2022-06-30 192.90 $5.43 35.52
2022-03-31 258.33 $5.26 49.11
2021-12-31 257.74 $5.21 49.47
2021-09-30 253.52 $4.97 51.01
2021-06-30 249.10 $5.46 45.62
2021-03-31 233.04 $3.69 63.16
2020-12-31 233.83 $4.20 55.67
2020-09-30 198.32 $4.61 43.02
2020-06-30 171.02 $4.21 40.62
2020-03-31 157.50 $5.69 27.68
2019-12-31 197.88 $5.48 36.11
2019-09-30 203.32 $9.02 22.54
2019-06-30 192.78 $9.34 20.64
2019-03-31 184.74 $9.27 19.93
2018-12-31 146.22 $9.34 15.66
2018-09-30 165.19 $3.24 50.98
2018-06-30 156.57 $2.83 55.33
2018-03-31 148.79 $2.67 55.73
2017-12-31 142.75 $2.68 53.26
2017-09-30 130.53 $4.68 27.89
2017-06-30 127.17 $4.48 28.39
2017-03-31 120.27 $4.45 27.03
2016-12-31 109.10 $4.35 25.08
2016-09-30 105.63 $4.39 24.06
2016-06-30 108.39 $4.24 25.56
2016-03-31 96.72 $4.27 22.65
2015-12-31 83.48 $3.78 22.09
2015-09-30 84.18 $3.07 27.42
2015-06-30 85.19 $2.44 34.92
2015-03-31 81.94 $1.97 41.59
2014-12-31 83.47 $1.57 53.17
2014-09-30 71.20 $1.91 37.28
2014-06-30 74.07 $2.02 36.67
2014-03-31 71.31 $2.02 35.30
2013-12-31 65.51 $2.63 24.91
2013-09-30 58.69 $2.33 25.19
2013-06-30 55.95 $2.98 18.78
2013-03-31 56.20 $3.27 17.19
2012-12-31 47.03 $3.39 13.87
2012-09-30 47.53 $3.73 12.74
2012-06-30 46.87 $3.65 12.84
2012-03-31 47.00 $3.59 13.09
2011-12-31 41.95 $3.46 12.13
2011-09-30 39.61 $3.15 12.57
2011-06-30 49.14 $3.16 15.55
2011-03-31 50.75 $3.17 16.01
2010-12-31 44.69 $3.19 14.01
2010-09-30 41.51 $3.21 12.93
2010-06-30 41.40 $2.93 14.13
2010-03-31 47.18 $2.86 16.49
2009-12-31 41.42 $2.77 14.95
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $154.023B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $220.159B 25.82
Boston Scientific (BSX) United States $157.028B 37.51
EssilorLuxottica (ESLOY) France $136.572B 0.00
Medtronic (MDT) Ireland $119.200B 16.90
Lonza Group Ag (LZAGY) Switzerland $50.282B 0.00
Haleon (HLN) United Kingdom $44.384B 25.33
ResMed (RMD) United States $40.346B 30.30
GE HealthCare Technologies (GEHC) United States $35.536B 16.87
Agilent Technologies (A) United States $34.139B 22.26
Terumo (TRUMY) Japan $25.843B 33.57
Koninklijke Philips (PHG) Netherlands $25.190B 17.68
Insulet (PODD) United States $20.424B 80.17
Zimmer Biomet Holdings (ZBH) United States $19.300B 12.40
Baxter (BAX) United States $14.995B 11.20
Smith & Nephew SNATS (SNN) United Kingdom $13.871B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $7.189B 25.02
Lantheus Holdings (LNTH) United States $5.046B 12.73
Perrigo (PRGO) Ireland $3.908B 9.91
Prestige Consumer Healthcare (PBH) United States $3.799B 16.97
Haemonetics (HAE) United States $3.613B 16.46
Envista Holdings (NVST) United States $3.525B 29.30
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.197B 23.58
LeMaitre Vascular (LMAT) United States $1.862B 41.63
QuidelOrtho (QDEL) United States $1.852B 12.74
AtriCure (ATRC) United States $1.559B 0.00
Acuren (TIC) United States $1.441B 0.00
Green Thumb Industries (GTBIF) United States $1.332B 29.95
AdaptHealth (AHCO) United States $1.274B 12.93
Phibro Animal Health (PAHC) United States $1.183B 15.12
Neogen (NEOG) United States $1.133B 14.50
BioLife Solutions (BLFS) United States $1.080B 0.00
Curaleaf Holdings (CURLF) Canada $0.964B 0.00
InMode (INMD) Israel $0.930B 9.38
Kestra Medical Technologies (KMTS) United States $0.850B 0.00
Tilray Brands (TLRY) Canada $0.693B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.685B 0.00
Valneva SE (VALN) France $0.654B 0.00
Evolus (EOLS) United States $0.614B 0.00
Owens & Minor (OMI) United States $0.609B 5.05
CeriBell (CBLL) United States $0.547B 0.00
ZimVie (ZIMV) United States $0.521B 23.70
Surmodics (SRDX) United States $0.515B 0.00
SNDL (SNDL) Canada $0.398B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.359B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
Sanuwave Health (SNWV) United States $0.324B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Capricor Therapeutics (CAPR) United States $0.322B 0.00
Quanterix (QTRX) United States $0.292B 0.00
Aurora Cannabis (ACB) Canada $0.272B 80.67
Cerus (CERS) United States $0.266B 0.00
OraSure Technologies (OSUR) United States $0.251B 0.00
Viemed Healthcare (VMD) United States $0.242B 20.40
Biote (BTMD) United States $0.236B 6.65
Canopy Growth (CGC) Canada $0.234B 0.00
Verano Holdings (VRNOF) United States $0.230B 0.00
Sanara MedTech (SMTI) United States $0.227B 0.00
Omeros (OMER) United States $0.224B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Organigram Global (OGI) Canada $0.205B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.65
High Tide (HITI) Canada $0.188B 0.00
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
Vireo Growth (VREOF) United States $0.170B 0.00
Exagen (XGN) United States $0.155B 0.00
TerrAscend (TSNDF) Canada $0.135B 0.00
FitLife Brands (FTLF) United States $0.121B 14.91
MacroGenics (MGNX) United States $0.108B 0.00
Jin Medical (ZJYL) China $0.102B 0.00
Jushi Holdings (JUSHF) United States $0.101B 0.00
Fonar (FONR) United States $0.100B 12.86
Quipt Home Medical (QIPT) United States $0.097B 0.00
Apyx Medical (APYX) United States $0.096B 0.00
Safety Shot (SHOT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Veru (VERU) United States $0.082B 0.00
Zynex (ZYXI) United States $0.078B 0.00
Agape ATP (ATPC) $0.066B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Cytosorbents (CTSO) United States $0.059B 0.00
Modular Medical (MODD) United States $0.039B 0.00
United-Guardian (UG) United States $0.038B 13.29
Nephros (NEPH) United States $0.038B 51.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.023B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Senestech (SNES) United States $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00